Bionara Ultra Capsule
NDC Package 85477-710-30
Package Information
Bionara Ultra (probiotic dietary supplement capsules) capsules is bionara Ultra™ is a prescription probiotic supplement intended to support gastrointestinal health and maintain normal intestinal flora balance.Dispensed by prescription under medical supervision. This formulation utilizes a capsule delivery system. Marketed by Oncora Pharma, Llc, this product is identified by NDC 85477-710.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85477 - Oncora Pharma, Llc
- 85477-710 - Bionara Ultra
- 85477-710-30 - 30 CAPSULE in 1 BOTTLE
- 85477-710 - Bionara Ultra
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85477-710-30 identifies a specific commercial package of 30 capsule in 1 bottle of Bionara Ultra, a human prescription drug labeled by Oncora Pharma, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This capsule is formulated for oral use and contains beta vulgaris root fructooligosaccharides; bifidobacterium animalis lactis bl04; lacticaseibacillus paracasei lpc-37; lactiplantibacillus plantarum; lactobacillus acidophilus la 14; lessonia nigrescens as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Oncora Pharma, Llc on February 23, 2026. The current certification is valid through December 31, 2027.
How is this Oncora Pharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85477071030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.